Working for consumer rights, safe medicines and products
Printer-friendly versionPharmaWatch’s blog seeks to shed light on some of the most significant policy, research, legislative and program issues related to the safety and efficacy of prescription drugs, vaccines and medical devices in Canada. They believe that the Canadian public, patients, physicians, policy analysts, researchers, academics, authors, politicians and the media have a right to know how our drug approval and monitoring system works, how it compares to other international jurisdictions, the factors influencing decision making and whether Health Canada is protecting our health and safety.
The Canadian Women's Health Network and the Centres of Excellence for Women's Health program are financially supported by Health Canada through the Women's Health Contribution Program. The views herein do not necessarily represent the official policy of Health Canada.